Headline News about Beigene Ltd ADR
![](https://cdn.benzinga.com/files/images/story/2022/12/12/image-paypal.png?width=1200&height=800&fit=crop)
Via Benzinga
What 5 Analyst Ratings Have To Say About BeiGene
December 12, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
Will Investors Notice Exciting Sign On BeiGene's Chart?
December 06, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/711264/biontech.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/image-workday.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7309.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/706398/gettyimages-1209892070.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/image49.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/image11.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/14/aapharma_6.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5532.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/23/image-dollar_tree_.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/09/shutterstock_1946121031.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/19/aapharma_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/innovent.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/20/aapharma_0.png?width=1200&height=800&fit=crop)
UK's NICE Recommends BeiGene's Cancer Drug For Rare Form Of Blood Cancer
September 20, 2022
Via Benzinga
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28050.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/10/IT04-BeiGene-05-news.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/12/aapharma_6.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/aapharma_2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/junshi.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/china-us.png)
![](https://investorplace.com/wp-content/uploads/2019/08/stocks-to-sell.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/30/image-bed_bath__beyond.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/30/image20.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/25/image21_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/25/image-tesla3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/23/bz-pharma_4.jpg?width=1200&height=800&fit=crop)
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 23, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.